scispace - formally typeset
A

Alex E. Green

Researcher at McMaster University

Publications -  20
Citations -  1070

Alex E. Green is an academic researcher from McMaster University. The author has contributed to research in topics: AMPK & Lipogenesis. The author has an hindex of 11, co-authored 20 publications receiving 717 citations. Previous affiliations of Alex E. Green include University of Ottawa & Albert Einstein Medical Center.

Papers
More filters
Journal ArticleDOI

Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function

TL;DR: In response to a high-fat diet, iβ1β2AKO mice more rapidly developed liver steatosis as well as glucose and insulin intolerance, and AMPK in adipocytes is vital for maintaining mitochondrial integrity, responding to pharmacological agents and thermal stress, and protecting against nutrient-overload-induced NAFLD and insulin resistance.
Journal ArticleDOI

AMPK Activation of Muscle Autophagy Prevents Fasting-Induced Hypoglycemia and Myopathy during Aging

TL;DR: It is reported that fasting mice lacking skeletal muscle AMPK (AMPK-MKO) results in hypoglycemia and hyperketosis, establishing an essential requirement for skeletal Muscle AMPK-mediated autophagy in preserving blood glucose levels during prolonged fasting as well as maintaining muscle integrity and mitochondrial function during aging.
Journal ArticleDOI

Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule

TL;DR: Physiological inhibition of serotonin synthesis or signaling in key metabolic tissues are potential drug targets for obesity and non-alcoholic fatty liver disease and peripheral serotonin acts as an endocrine factor to promote the efficient storage of energy by upregulating lipid anabolism.
Journal ArticleDOI

The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration

TL;DR: Clinical efficacy studies evaluating the clinical efficacy of Canagliflozin on limiting tumorigenesis in pre-clinical animal models and epidemiological studies on cancer incidence relative to other glucose lowering therapies in clinical populations are supported.
Journal ArticleDOI

Radioimmunoassay for nanogram quantities of DNA.

TL;DR: A direct competitive binding radioimmunoassay for DNA has been developed, using 125I-iododeoxyuridine-labelled DNA as the antigen and the serum from a patient with systemic lupus erythematosus.